Our study aimed at inhibiting the expression of CD47 gene in the tumor cells to reduce immune escape, activating antigen-presenting cells (APCs), and eliminating the tumor immunosuppressive microenvironment through the construction of siCD47 and R848-loaded nanoparticles. The gene discussed is CD47; the disease is neoplasm.